Cariprazine Relative to Placebo in the Prevention of Relapse of Symptoms in Patients With Schizophrenia
This study has been completed.
Gedeon Richter Ltd.
Information provided by (Responsible Party):
First received: August 4, 2011
Last updated: September 25, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||November 2014|
|Primary Completion Date:||August 2014 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||September 25, 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Durgam S, Earley W, Li R, Li D, Lu K, Laszlovszky I, Fleischhacker WW, Nasrallah HA. Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial. Schizophr Res. 2016 Oct;176(2-3):264-71. doi: 10.1016/j.schres.2016.06.030.